Inability of cytoprotection to occur during a period of gastric ischemia.
Prostaglandin E2 (PGE2), colloidal bismuth subcitrate (CBS), and sucralfate (SUC) are known to protect the gastric mucosa from ethanol injury. The proposed central role for the microcirculation in gastric mucosal defense and as a site for the expression of the protective effects of these agents was investigated in the rat stomach. Animals were pretreated with either PGE2, CBS, or SUC. Control rats were given normal saline. After allowing 15 min for expression of the pretreatment, ethanol was administered as a 10%, 25%, 50%, or 100% solution to groups of rats with normally perfused stomach and to other groups of rats in whom the stomach was made ischemic by cross-clamping the supracoeliac aorta immediately prior to the instillation of ethanol. The extent of gastric mucosal damage was measured using quantitative histological techniques and expressed as a percentage of surface area and volume of mucosa damaged. In the presence of ischemia, the extent of damage by ethanol was markedly increased, with total destruction of the mucosa by the 50% and 100% solutions. With 25% ethanol, the volume of mucosal damage was increased from 0.5% in the normally perfused stomach to 53.5% with ischemia. When 10% ethanol was instilled into the ischemic stomach, only 0.8% of the volume of the mucosa was damaged, which was not different from the volume of mucosa damaged after the ischemic stomach was exposed to normal saline alone (1.0%). Pretreatment with PGE2, CBS, or SUC did not significantly change the extent of damage seen with exposure of the ischemic stomach to 25% or 50% ethanol.(ABSTRACT TRUNCATED AT 250 WORDS)
Frydman
G M
GM
Department of Surgery, Monash University, Alfred Hospital, Melbourne, Australia.
Penney
A G
AG
Malcontenti
C
C
O'Brien
P E
PE
D000818:Animals; D000863:Antacids / Q000494:pharmacology; D015232:Dinoprostone / Q000494:pharmacology; D000431:Ethanol / Q000633:toxicity*; D005753:Gastric Mucosa / Q000098:blood supply* / Q000187:drug effects* / Q000473:pathology; D007511:Ischemia / Q000503:physiopathology*; D008297:Male; D008833:Microcirculation / Q000502:physiology; D009336:Necrosis / Q000517:prevention & control; D009942:Organometallic Compounds / Q000494:pharmacology; D051381:Rats; D013392:Sucralfate / Q000494:pharmacology
D000863:Antacids; D009942:Organometallic Compounds; D000431:Ethanol; D013392:Sucralfate; C002791:bismuth tripotassium dicitrate; D015232:Dinoprostone